The global reusable bioreactors market was valued at USD 9.6 billion in 2025 and is projected to reach USD 24.7 billion by 2035, representing a compound annual growth rate of 9.9%, according to a report added to ResearchAndMarkets.com's offering on Sept. 24, 2026. Demand is being supported by pharmaceutical and biotechnology expansion, rising biologics production, personalized therapies and advances in bioprocessing. Reusable bioreactors provide durable, scalable and controlled systems for high-volume manufacturing, while automation, real-time monitoring, process control, and integrated cleaning and sterilization technologies are improving productivity, quality consistency and uptime. Mammalian cells generated USD 7.7 billion in 2025, while vaccine applications accounted for USD 3.6 billion. North America held 38.9% of the global market in 2025. The 180-page report covers market forecasts through 2035, segmentation by cell type, molecule, usage, material, size, end use and region, as well as industry trends, challenges, opportunities, regulatory developments, technology, pricing, patents, competitive dynamics and company strategies. It identifies investments in automation, monitoring, sterilization, scalability, compliance, customized bioprocessing, capacity and distribution as key competitive priorities.